BioSpace News Archive

Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test.

Poseida Therapeutics, Inc., (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today will present data related to its proprietary manufacturing process designed to optimize its CAR-T product candidates.

The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US Medical Innovations, LLC (USMI) announced today that Canady Helios™ Cold Plasma (CHCP) has been used as an effective inhibitor of cell viability in breast cancer molecular subtypes.

The American College of Lifestyle Medicine (ACLM) today announced availability of its new groundbreaking CME- and CE-accredited course, “Reversing Type 2 Diabetes and Insulin Resistance with Lifestyle Medicine.”

Inflammasome Therapeutics, a private, science-based company developing therapies for prevalent, degenerative diseases as well as sustained-release drug delivery systems, announced it has been awarded a $1.0-million grant to develop a long-term bioerodible birth control implant.

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE, the Company’s prospective safety study of the IMPEDE-FX Embolization Plug devices when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR).

Paradigm4, specialist in scientific data management and scalable computation, has launched its REVEAL: Single CellTM app to offer biopharmaceutical developers the ability to break through the data wrangling and programming challenges associated with the analysis of large-scale, single-cell datasets.

ContinuumRx, a provider of home infusion and specialty pharmacy services based in Birmingham, Alabama, announced today that Keith Hartman has been named Chief Executive Officer.

Solos Endoscopy, Inc. is pleased to announce it has completed the compatibility testing of its MammoView product line with The STERIS V-PRO 1 Low Temperature Sterilization System.

Havn Life Sciences Inc. is pleased to announce that it has been accepted to list its common shares on the Frankfurt Stock Exchange under the trading symbol.